Navigation Links
Treating Heart Disease Risk Factors May Slow Alzheimer's Disease,Progression

- Late Life Weight Loss and "Motivational Reserve" May Also Affect Alzheimer's Risk -

WASHINGTON, June 10, 2007 /PRNewswire-USNewswire/ -- A new study suggests that treating risk factors for heart disease and stroke, such as high blood pressure and diabetes, may slow the progression of Alzheimer's disease, according to research reported today at the 2nd Alzheimer's Association International Conference on Prevention of Dementia in Washington, DC.

Two new studies presented at the conference further confirm the close relationship between heart health and brain health. A third report, this one from the Nun Study, suggests that unexplained weight changes in late life have an impact on dementia risk and also may be useful, when combined with other factors such as biomarkers, as an indicator for early detection of dementia. Finally, a team of scientists has developed a new concept called "motivational reserve," similar to "cognitive reserve," that may be related to incidence and progression of Alzheimer's.

"The best known and most solid risk factors for Alzheimer's are age, family history and genetics, but those are things you can't change," said William Thies, PhD, vice president of Medical and Scientific Relations for the Alzheimer's Association. "Research that identifies lifestyle risk factors gives people actions they can do, and positive choices they can make, to reduce their risk of Alzheimer's -- like lowering their blood pressure and treating their diabetes, or better still avoiding them in the first place. That's a good research investment."

Treating Vascular Risk Factors May Slow Progression of Alzheimer's

There is growing evidence that factors that increase the risk of vascular events like heart attack or stroke also increase the risk of cognitive decline; and that treatment of some vascular risk factors, such as use of blood pressure lowering medication, may reduce dementia occu
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Ceragenix Compound Shows Promise for Treating Lethal Cystic Fibrosis Infections
2. Eurands Zentase Effective in Treating Exocrine Pancreatic Insufficiency, Studies Show
3. XYOTAX More Cost Effective With Fewer Side Effects Than Gemcitabine or Vinorelbine in Treating Non-Small Cell Lung Cancer
4. Enzo Biochem Individualized Oral Immune Regulation Therapy May Be Effective Approach to Treating Crohns Disease
5. Positive Clinical Data on CC-10004 Confirms Potential as Novel Oral Approach to Treating Inflammatory Diseases
6. RTA 402 Shown to Inhibit STAT3 in Animal Model and Holds Significant Promise for Treating Breast Cancer
7. New Data Shows Once a Day Lamictal XR is Effective in Treating Patients with Partial Seizures
8. Targeting Specific Mutations Reveals Promising New Approach to Treating Genetic Disorders; Preclinical Data Published in Nature
9. Achillion Presents Positive Data on Novel Mechanism for Treating HCV at EASL Annual Meeting
10. Alexzas AZ-004 Phase IIa Trial Meets Primary Endpoint in Treating Schizophrenic Patients With Acute Agitation
11. Stanford Study Finds No Conclusive Benefit From Treating Kleptomania With Medication
Post Your Comments:
(Date:9/5/2008)... BOCA RATON, Fla., Sept. 5 /PRNewswire-USNewswire/...ip Board recently awarded Florida,Atlantic Univers...d,professor and director of the Center for Molecul...midt College of Science, and CHS,Resources LLC (CH...rch,Commercialization Assistance Grant program (SU...
(Date:9/5/2008)... VIENNA, Va., Sept. 5 /- CE...at it presented new rheumatoid arthritis data,at t...sterdam. The data,presented by Dr. Daniel Zimmerm...munology of CEL-SCI, indicate that CEL-SCI,s rheum...ds the permanent tissue damage,caused by rheumatoi...
(Date:9/5/2008)... MORGANTOWN, W.Va., Sept. 5 /PRNewswire-USNewswire...sity has shown that U.S. immigrants from,India and...try, increasing,their risks of prostate cancer amo...., "Breast cancer and prostate cancer develop due...festyle play a major role in these cancers,",said ...
(Date:9/4/2008)... MELBOURNE, Australia, Sept. 4 /- Cyt... commencing enrolment for its Phase Ib/II,study of...nticancer agent,in patients with an aggressive fo...e (GBM)., The GBM clinical trial is the first Pha...or indications for the company and the second in i...
Breaking Medicine Technology:Major State Grant Accelerates Research and Development of Novel Cancer Therapy 2Major State Grant Accelerates Research and Development of Novel Cancer Therapy 3Data Suggest CEL-SCI's CEL-2000 Vaccine Prevents or Retards Permanent Damage of Rheumatoid Arthritis 2Data Suggest CEL-SCI's CEL-2000 Vaccine Prevents or Retards Permanent Damage of Rheumatoid Arthritis 3Data Suggest CEL-SCI's CEL-2000 Vaccine Prevents or Retards Permanent Damage of Rheumatoid Arthritis 4Immigrants From India, Pakistan Face U.S. Prostate, Breast Cancer Risks 2Cytopia Commences Second Phase II Study in Brain Cancer 2Cytopia Commences Second Phase II Study in Brain Cancer 3Guardian Survey 3A Employees Are Confused About Their Health Coverage and Have No Plans for Healthcare in Retirement 19492 1Guardian Survey 3A Employees Are Confused About Their Health Coverage and Have No Plans for Healthcare in Retirement 19492 2Guardian Survey 3A Employees Are Confused About Their Health Coverage and Have No Plans for Healthcare in Retirement 19492 3Guardian Survey 3A Employees Are Confused About Their Health Coverage and Have No Plans for Healthcare in Retirement 19492 4Guardian Survey 3A Employees Are Confused About Their Health Coverage and Have No Plans for Healthcare in Retirement 19492 5BioElectronics Announces Conference Call to Update Investors on Growth Initiatives 5443 1BioElectronics Announces Conference Call to Update Investors on Growth Initiatives 5443 2BioElectronics Announces Conference Call to Update Investors on Growth Initiatives 5443 3Duane Reade Announces Proud Sponsorship of AIDS Walk New York 19488 1Duane Reade Announces Proud Sponsorship of AIDS Walk New York 19488 2Summit VetPharm Announces Grand Prize and March Winner in its Great Vectra 3D 28TM 29 24125 000 Giveaway 19483 1Summit VetPharm Announces Grand Prize and March Winner in its Great Vectra 3D 28TM 29 24125 000 Giveaway 19483 2
...ILLSIDE, NJ, March 12, 2007—InB:Biotechnolog...f Integrated BioPharma,Inc. (NASDAQ: INBP), today...accines against HPV, anthrax and plague made using...echnology. The,studies were conducted by the Fraun..., the Contract Research Organization led by Dr.,Vi...
...Tyrima Demonstrates Good Safety Profile and Excell...E PARK, N.C., March 13, 2007 /PRNewswire/ --,CeNeR...ping and,commercializing innovative treatments for...ounced top-line results from a Phase I,clinical tr...tment,of depression and anxiety. In this study, Ty...
Other Medicine Technology:Integrated BioPharma's Proprietary Vaccine Technology Achieves,Strong Positive Results 2CeNeRx BioPharma Announces Positive Phase I Results in First Human,Trial of Third Generation RIMA Antidepressant 2CeNeRx BioPharma Announces Positive Phase I Results in First Human,Trial of Third Generation RIMA Antidepressant 3
(Date:9/5/2008)... need to know what triggers them, experts say , ...you are one of the 36 million Americans who suffer...United States that is free from pollen and other a...gies don,t only happen in the spring, they can be ...the most challenging cities to live in are Greensb...
(Date:9/5/2008)...wire-USNewswire/ -- Speaker Nancy Pelosi,issued th... of the "Stand,Up to Cancer" telethon, to be aired... in our country who has not seen a loved one,suffe...s annually, and each,year there are more than 1.4 ...r to make eradicating the scourge of cancer a nati...
(Date:9/5/2008)...RNewswire/ -- On Saturday, September 6, PARI,Respi...twork show Today,s,Family as part of their "Breath... medical device company that provides patients, su...d compressors that deliver needed,medications dire... lives of those affected by respiratory,diseases a...
(Date:9/5/2008)...wire-USNewswire/ -- As the general election,campai...n of Independent,Business ( http://www.nfib.com ) ...a greater focus on the healthcare concerns of smal... conventions are over, NFIB,is asking both candida...ced,by small businesses as they further develop th...
Breaking Medicine News(10 mins):Health News:No Place Safe From Allergies 2Health News:PARI Respiratory Equipment Featured on Oxygen Network 2Health News:Conventions Conclude, Fall Campaign Begins: NFIB Looks for More Focus on Small Business Healthcare Concerns 2Health News:Conventions Conclude, Fall Campaign Begins: NFIB Looks for More Focus on Small Business Healthcare Concerns 3
...che Diagnostics today announces that it has comple...merger agreement with BioVeris for approximately $...iagnostics now owns the patents for Electrochemilu...expand its immunochemistry business from the human...
...arly 100 people have been bitten and injured by a ...e no anti-rabies vaccines in the government hospit..., the jackal has attacked and injured villagers - ...ren - in half a dozen villages under the Manjhagar...
...betan refugees plan to introduce organic farming i...t organic village will be set up in each of the 12...a," said Ngodup Dorje, head of the agriculture and...f the Tibetan government-in-exile here. The model...
...UN report on drugs has officially declared Britain...aily Mail report, over 900,000 Britons buy cocaine...he biggest user in the continent. In addition, Bri...users are the largest number in any country in Eur...
Other Medicine News:
The Diagnostic Automation, Inc. (DAI) Myeloperoxidase (MPO) Enzyme-Linked Immunosorbent Assay (ELISA) is intended for the detection and semi-quantitative determination of IgG, A, M antibodies to MPO
Anti-RSV IgA Assay (ELISA).
Anti-RSV IgG Assay (ELISA).
Rapid Immunoassay for the detection of Respiratory Syncytial Virus.
Medicine Products: